Toyama, Japan

Hiroko Matsukura



Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hiroko Matsukura in Pharmaceutical Chemistry

Introduction

Hiroko Matsukura is a prominent inventor based in Toyama, Japan, recognized for her significant contributions to the field of pharmaceutical chemistry. With a total of two patents to her name, her work reflects a commitment to advancing drug development methodologies.

Latest Patents

Hiroko’s latest innovations involve the processes for producing 7-isoindoline-quinolonecarboxylic acid derivatives and their intermediates. These patents also cover the salts of 7-isoindoline-quinolonecarboxylic acids, hydrates thereof, and compositions that include these compounds as active ingredients. Her focus on these derivatives highlights the importance of innovative approaches in creating effective pharmaceutical products.

Career Highlights

Hiroko Matsukura is currently affiliated with Toyama Chemical Co., Ltd., where she plays a vital role in research and development. Her work is focused on the synthesis of complex chemical compounds aimed at addressing various health challenges. Throughout her career, she has gained recognition for her methodical approach to innovation in chemistry.

Collaborations

In her professional endeavors, Hiroko collaborates closely with colleagues Minoru Yamada and Shoichi Hamamoto. These collaborations foster a dynamic environment that promotes the sharing of ideas and accelerates the innovation of new chemical processes that can have a significant impact on pharmaceutical applications.

Conclusion

Hiroko Matsukura’s contributions to the field of pharmaceutical chemistry through her innovative patents exemplify the critical role of inventors in advancing healthcare solutions. Her ongoing work at Toyama Chemical Co., Ltd. and her collaborations with talented colleagues continue to pave the way for future breakthroughs in drug development. With her dedication and expertise, Hiroko remains a key figure in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…